Milk Thistle Stacks: Dandelion, Berberine, NAC and TUDCA

Search any of these pairings and you will find pages explaining what each combination is good for. None of them mentions that the ingredient every stack is built on returned a null result in the best synthesis available.

Start with the base

A Cochrane review pooled 18 randomised trials, 1,088 patients with alcoholic or hepatitis B or C virus liver disease, comparing milk thistle against placebo or no intervention.

Outcome	Result
All-cause mortality	RR 0.78 (95% CI 0.53–1.15)
Complications of liver disease	RR 0.95 (0.83–1.09)
Liver histology	No significant effect

Every one of those confidence intervals contains 1. No significant effect on any of them.

The authors’ own words: their results question the beneficial effects of milk thistle and highlight the lack of high-quality evidence.

The number worth learning from

There is one outcome where milk thistle did reach significance, and what happened to it is the most instructive thing in this whole subject.

Liver-related mortality, all trials: RR 0.50 (95% CI 0.29–0.88). Significant. A halving.

Liver-related mortality, high-quality trials only: RR 0.57 (95% CI 0.28–1.19). Not significant.

Same direction. Similar magnitude. The significance disappears the moment you remove the poorly conducted studies.

And there were a lot to remove: only 28.6% of the trials reported high methodological quality characteristics.

That pattern, an effect that exists across all studies and evaporates in the good ones, is the textbook signature of bias. It is also exactly the number that gets quoted on supplement pages, because 0.50 makes a better headline than 0.57 with a confidence interval crossing 1.

What NCCIH says

Results from clinical trials of milk thistle for liver diseases… have been conflicting or too limited to allow conclusions to be reached.

And more pointedly, two NCCIH-funded studies did not show benefits from supplementation with silymarin.

Its summary position: there is not enough high-quality evidence to allow definite conclusions about the effects of milk thistle on health conditions in people.

So what do the stacks add?

Nothing that has been tested. We could not find a controlled trial of milk thistle with dandelion, with berberine, or with NAC, as a combination.

That matters more than it sounds. A stack is not a way of accumulating evidence. Two ingredients that have each been studied separately do not produce a combination that has been studied, and when the better-studied of the pair returns a null result, adding a less-studied herb does not repair it.

Dandelion is the most-searched pairing and the least-studied. Berberine has a real literature, but around glucose and lipids rather than liver outcomes, and it carries genuine interaction potential worth raising with a clinician. TUDCA appears constantly in head-to-head comparisons against milk thistle for which no head-to-head trial exists.

NAC is the exception, and not in the way it is sold

N-acetylcysteine is the one ingredient here with an unambiguous liver credential:

NAC has Federal and Drug Administration (FDA) approval for the treatment of potentially hepatotoxic doses of acetaminophen.

It works by repleting glutathione reserves through providing cysteine, and it is described as almost 100% effective if given within 8 hours post-ingestion.

Now read what that actually describes. An antidote, for an acute poisoning, in a narrow time window, given in hospital.

That is close to the opposite of a daily supplement for general liver support. The evidence is strong and it is strong for something specific, and stretching it into “NAC protects your liver, take it every morning” is borrowing credibility from a use case that does not apply.

On the framing itself

The liver is the organ that performs detoxification. A product that detoxes it is a slightly circular proposition to begin with.

But the useful version of the argument is narrower. In people with actual liver disease, the best-studied liver supplement did not change mortality, did not change complications, and did not change histology.

If something does not measurably help a damaged liver, the case that it improves a healthy one is weaker rather than stronger.

What is genuinely established

Safety. NCCIH describes milk thistle as well tolerated orally, with bloating, nausea and gas as the common side effects. Cochrane found no significantly increased risk of adverse events, RR 0.83 (0.46–1.50).

So this is a low-harm supplement with weak efficacy evidence, which is a different thing from a dangerous one. The cost of taking it is mostly the money.

The one real caution is interactions. NCCIH’s advice: if you take any type of medicine, talk with your health care provider before using milk thistle or other herbal products, because some herbs and medicines interact in harmful ways. That applies with more force to a stack than to a single ingredient, because you have multiplied the number of things that could interact without multiplying the evidence that any of them help.

Why there is no product recommendation here

Because the finding does not support one. An article concluding that the base ingredient’s benefits are questioned by the best available review, and that no combination has been tested, cannot honestly end with a button.

If your liver enzymes are raised or you have a diagnosed liver condition, that is a conversation with a doctor, and it is a conversation where what you are already taking is relevant information.